Medtronic plc (MDT)
What changed in recent filings
- Institutions — 5 added · 1 reduced13F · as of end of 2026 Q2
- Risk factors — 4 added · 4 removed · new: We are subject to litigation, claims, inves… +310-K Apr 25, 2025 → Apr 24, 2026 · filed 4 months ago
- Free cash flow declined recentlyJan 23, 2026 → Jul 31, 2026
What changed in recent SEC filings — factual, not a buy/sell recommendation.
Medtronic plc recent earnings releases
Based on SEC filings. The release date is the day the earnings filing (8-K) was accepted; for quarters where that filing was not found, the periodic report filing date is shown.
- 26Q2Released Sep 1, 2026Revenue +13.7% YoY · EPS $1.14Released before the open: Aug 31 close → Sep 1 close, the stock moved +1.5% · over the same window, market -0.7% · sector +0.2%
- 26Q1Released Jun 3, 2026Revenue +9.9% YoY · EPS $0.97Released before the open: Jun 2 close → Jun 3 close, the stock moved +5.7% · over the same window, market -0.7% · sector +0.8%
- 25Q4Released Feb 17, 2026Revenue +8.7% YoY · EPS $0.89Released before the open: Feb 13 close → Feb 17 close, the stock moved -3.1% · over the same window, market +0.2% · sector -0.3%
- 25Q3Released Nov 18, 2025Revenue +6.6% YoY · EPS $1.07Released before the open: Nov 17 close → Nov 18 close, the stock moved +4.7% · over the same window, market -0.8% · sector +0.5%
The next earnings release is estimated around Nov 17, 2026 (calculated from how long this company has taken between quarter end and filing; it is not a date announced by the company).
Institutions holding Medtronic plc
How many of the institutions we track reported holding this stock, quarter by quarter.
2019 Q1: 7 → 2026 Q2: 8 institutions
Counts the 52 institutions we track that reported holding this stock — their full reported holdings, not just the largest positions. Not the total number of institutional holders in the US. Figures are as of quarter-end and disclosed up to 45 days later. Descriptive only — not investment advice.
Which institutions hold Medtronic plc
Institutions we track that reported holding this stock in their most recent 13F.
- Dodge & Cox0.32% of portfolio · held as of 2019 Q1 or earlier
- Baillie Gifford & Co0.03% of portfolio · since 2020 Q4
- Caisse de depot (Quebec)0.02% of portfolio · since 2022 Q1
- Pzena Investment Management0.72% of portfolio · since 2023 Q1
- Bridgewater Associates0.15% of portfolio · since 2024 Q1
- National Pension Service (Korea)0.16% of portfolio · since 2024 Q1
- Capital World Investors0.08% of portfolio · since 2025 Q1
- Tudor Investment Corp0.01% of portfolio · since 2026 Q1
Based on 13F filings — quarter-end holdings, disclosed up to 45 days later. Holding a stock is a fact we report, not a recommendation to buy or sell.
Q2 2026 13F recap — stocks several institutions bought and sold together →Company overview
Medtronic. The world's largest medical-device company. It holds a broad product range in cardiac, neuro, spine, and diabetes fields.
What is the Biotech & Health sector?
Pharma, biotech, and medical devices. Driven by trial-result events.
Medtronic plc is classified under the Biotech & Health sector. See peers below.
Medtronic plc key financials
Based on SEC filings · as of Jul 31, 2026
Tap a metric name to see its meaning in the glossary.
Medtronic plc vs Biotech & Health sector benchmark
Median of 38 representative sector stocks · SEC filings · factual comparison (not advice)
A simple comparison to the sector benchmark. Higher or lower doesn’t mean good/bad or buy/sell.
ETFs holding Medtronic plc
Per SEC N-PORT · 2026-06-30 · by weight · factual
MDT on Stocklore
- Revenue by segment — segment weights verified from SEC filings, YoY changes, growth drivers and concentration
- Financials & earnings quality — 6 metrics (FCF conversion, ROIC, net debt, etc.) to gauge profit quality
- 13F institutional holdings — holdings and weight changes of major institutions (45-day delay)
- Sector-relative metrics — Valuation and growth compared with the Biotech & Health average
Peers · Biotech & Health
MDT FAQ
What is Medtronic plc (MDT)?
Medtronic. The world's largest medical-device company. It holds a broad product range in cardiac, neuro, spine, and diabetes fields.
What sector is Medtronic plc in?
Medtronic plc is classified under Biotech & Health. Pharma, biotech, and medical devices. Driven by trial-result events.
What are Medtronic plc's key financials?
As of Jul 31, 2026 in SEC filings: Revenue growth (YoY) 9.8%, Operating margin 18.1%, Net margin 13.9%, ROE 9.7%, Debt-to-equity 0.51x. Definitions and interpretation are available on Stocklore.
Where can I analyze Medtronic plc (MDT) stock?
On Stocklore you can see MDT's financials & earnings quality, 13F institutional holdings, and sector-relative metrics in one place. This page is for information and tools — not a buy/sell recommendation.
Data sources: SEC EDGAR (financials & filings), 13F (institutional holdings, as of quarter-end), market data. This page is for information and analysis tools — it does not recommend buying or selling any security. Investment decisions and responsibility are your own.